According to our (Global Info Research) latest study, the global Molecular Pathology Services market size was valued at US$ 166 million in 2025 and is forecast to a readjusted size of US$ 279 million by 2032 with a CAGR of 7.4% during review period.
Molecular Pathology Services refer to laboratory and consultative pathology services that use DNA-, RNA-, and biomarker-based testing methods to support disease diagnosis, classification, prognosis, therapy selection, and treatment monitoring. These services commonly integrate PCR, NGS, FISH, sequencing, liquid biopsy, pathology interpretation, and clinical reporting into a unified diagnostic workflow.
This report is a detailed and comprehensive analysis for global Molecular Pathology Services market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Molecular Pathology Services market size and forecasts, in consumption value ($ Million), 2021-2032
Global Molecular Pathology Services market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Molecular Pathology Services market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Molecular Pathology Services market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Molecular Pathology Services
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Molecular Pathology Services market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Quest Diagnostics, Labcorp, Sonic Healthcare, NeoGenomics, Foundation Medicine, Caris Life Sciences, Tempus, Guardant Health, Exact Sciences, Eurofins, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Molecular Pathology Services market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Solid Tumor Molecular Pathology Services
Hematologic Malignancy Molecular Pathology Services
Hereditary Disease Molecular Pathology Services
Infectious Disease Molecular Testing Services
Rare Disease Molecular Pathology Services
Others
Market segment by Service Content
Single-Gene Testing Services
Targeted Panel Testing Services
Comprehensive Genomic Profiling Services
Companion Diagnostic Support Services
Pathology Consultation and Interpretation Services
Others
Market segment by Application
Hospitals and Medical Centers
Independent Clinical Laboratories
Academic and Research Institutes
Biopharmaceutical Companies
Others
Market segment by players, this report covers
Quest Diagnostics
Labcorp
Sonic Healthcare
NeoGenomics
Foundation Medicine
Caris Life Sciences
Tempus
Guardant Health
Exact Sciences
Eurofins
Unilabs
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Molecular Pathology Services product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Molecular Pathology Services, with revenue, gross margin, and global market share of Molecular Pathology Services from 2021 to 2026.
Chapter 3, the Molecular Pathology Services competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Molecular Pathology Services market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Molecular Pathology Services.
Chapter 13, to describe Molecular Pathology Services research findings and conclusion.
Summary:
Get latest Market Research Reports on Molecular Pathology Services. Industry analysis & Market Report on Molecular Pathology Services is a syndicated market report, published as Global Molecular Pathology Services Market 2026 by Company, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Molecular Pathology Services market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.